Sorrento Therapeutics is a development-stage biopharmaceutical company engaged in the acquisition, discovery, development and commercialization of proprietary drug therapeutics for addressing significant unmet medical needs. Sorrento’s late stage pipeline include Cynviloq™ (paclitaxel in polymeric micelle formulation) currently in a registrational bio-equivalent study versus albumin-bound paclitaxel; and Resiniferatoxin (RTX),which is in a Phase 1/2 study at the NIH to treat terminal cancer patients suffering from intractable pain. Sorrento has one of the industry’s most diverse antibody (G-MAB®) library comprised of high-quality, fully human antibodies with a diversity of more than ten trillion (>10^16). Along with its' proprietary conjugation chemistries and novel toxins, Sorrento has all in-house capabilities to generate and develop a new generation of homogenous ADCs with well-defined drug antibody ratios (DAR) in contrast to approved ADCs, which are heterogeneous mixtures with different DARs. These differentiating characteristics may lead to improved ADC stability and pharmacokinetics while reducing off-target effects compared to existing ADCs. Sorrento's primary therapeutic focus is cancer although its products and technologies have much broader clinical applications including autoimmune disorders, metabolic diseases and infectious diseases.

Mestex is one of the important clusters for innovative pharmaceutical industries and biotech companies in Europe. Mestex AG is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the intra-articular treatment of pain associated with osteoarthritis of the knee.

Research Development Foundation is an American private company that operates as noncommercial research organizations.

AmorePacific Group, Inc. engages in the management of its subsidiaries. Through its subsidiaries it offers cosmetics, hair care, medical products, cosmetic glass containers, tea raw materials, and printing equipment. The company was founded on March 6, 1959 and is headquartered in Seoul, South Korea.

Manufactures pharmaceuticals for treating degenerative brain diseases

Medifron DBT Co., Ltd. engages in the provision of information technology (IT) content services. It operates through the IT and New Medicine business divisions. The IT business division offers interactive voice response system which provides consultation, voicemail, automatic guidance, video conferencing, predictive dialing, audiotext, voice processing function, help desk function, collaborative computing, call switching, and call control. The New Medicine business division develops drugs and diagnostic device for the treatment of central nervous system diseases. The company was founded on March 18, 1997 and is headquartered in Seoul, South Korea.

Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.

Nestec SA, a subsidiary of Nestlé SA, is a Swiss company located in Vevey. The firm manufactures nutrition food products.

Board of Trustees of Southern Illinois University, a subsidiary of Southern Illinois University, is an American company located in Carbondale, IL. The firm provides trust services.

R.P. Scherer GmbH & Co. KG, part of Catalent, Inc., is a company headquartered in Eberbach, Germany, that develops, manufactures and sells pharmaceutical products.

Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain. Its product pipeline includes CNTX-4975, CNTX-0290, CNTX-6970, CNTX-2022, CNTX-6016, and intrathecal platform. The company was founded by Sol J. Barer and Jeffrey B. Kindler in February 2013 and is headquartered in Boston, MA.

Reckitt Benckiser Healthcare (UK) Ltd., a subsidiary of Reckitt Benckiser Group Plc, is a British company located in Slough. The firm manufactures household and sanitary goods. It was founded in 1931.\nThe company says this about itself: The principal activity of the company which is a Member of the Reckitt Benckiser group of companies is the manufacture and sale of branded consumer products for sale to other Group companies.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Established in 1945, Amorepacific is Korea’s No.1 beauty company and a blue-chip corporation. Amorepacific owns nearly 30 well-known brands and has been developing rapidly worldwide. Amorepacific pays great attention to product research and development through research centers located in Korea, France, Japan and Shanghai, to develop premium and high quality skincare and cosmetics products. The Group chose Hong Kong as a strategic bridgehead for the expansion of its presence across the Greater China region and the rest of the world. Two flagship brands - LANEIGE and Sulwhasoo, were introduced in Hong Kong in 2002 and 2004 respectively. The eponymous luxury brand – AMOREPACIFIC, was introduced in Hong Kong in 2014. In 2015, ETUDE HOUSE, a playful cosmetics brand, made its debut in the territory. In 2018, the Company set foot in the personal care product market, introducing the Group’s legendary hair care brand ‘Ryo’ into Hong Kong.

Xiamen Chaoyang Biological Engineering Co., Ltd., established on 2006-03-07, The scope of business includes the manufacture of chemical preparations;Chinese herbal medicine processing;Chinese patent medicine production;Biopharmaceutical Manufacturing;Sanitary materials and medical supplies manufacturing;Manufacturing of chemical raw materials(Free of hazardous chemicals, monitored chemicals and non-pharmaceutical precursor chemicals);marine services;Biotechnology Extension Services;Import and export of various commodities and technologies(Import and export commodity catalog is not attached),Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;Own real estate business activities.